|Day's Range||42.16 - 42.60|
|52 Week Range||37.03 - 53.62|
|PE Ratio (TTM)||38.18|
|Dividend & Yield||0.00 (0.00%)|
|1y Target Est||33.82|
Dr. Reddy's Laboratories will announce results for the First Quarter ended June 30, 2017 on Thursday, July 27, 2017 after the Board Meeting.
Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Dr. Reddy’s Laboratories Ltd. Here are 5 ETFs with the largest exposure to RDY-US. Comparing the performance and risk of Dr. Reddy’s Laboratories Ltd. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower ... Read more (Read more...)
Dr. Reddy’s Laboratories Limited today announced that its Annual Report on Form 20-F, containing its annual consolidated financial statements for the fiscal year ended 31 March, 2017 was filed with the United States Securities and Exchange Commission on June 19, 2017.